BR100 Increased By (1.02%)
BR30 Increased By (1.71%)
KSE100 Increased By (0.58%)
KSE30 Increased By (0.65%)
BECO 6.03 Increased By ▲ 0.26 (4.51%)
BML 52.61 Decreased By ▼ -0.39 (-0.74%)
BOP 34.23 Increased By ▲ 0.24 (0.71%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.23 Increased By ▲ 0.03 (0.25%)
FCCL 53.80 Increased By ▲ 0.97 (1.84%)
FCSC 5.24 Increased By ▲ 0.17 (3.35%)
FFL 18.03 Increased By ▲ 0.08 (0.45%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.00 Increased By ▲ 0.12 (1.1%)
KEL 8.07 Increased By ▲ 0.05 (0.62%)
KOSM 5.39 Decreased By ▼ -0.13 (-2.36%)
MLCF 87.90 Increased By ▲ 1.39 (1.61%)
NBP 186.60 Increased By ▲ 1.44 (0.78%)
PACE 10.75 Increased By ▲ 0.17 (1.61%)
PAEL 39.95 Increased By ▲ 0.53 (1.34%)
PIAHCLA 26.19 Decreased By ▼ -0.03 (-0.11%)
PIBTL 17.32 Increased By ▲ 0.65 (3.9%)
PPL 233.49 Increased By ▲ 5.31 (2.33%)
PRL 34.98 Increased By ▲ 0.30 (0.87%)
PTC 67.71 Increased By ▲ 2.38 (3.64%)
SEARL 90.90 Increased By ▲ 0.77 (0.85%)
SSGC 27.20 Increased By ▲ 0.60 (2.26%)
TELE 8.57 Increased By ▲ 0.29 (3.5%)
THCCL 60.85 Increased By ▲ 2.35 (4.02%)
TPLP 8.78 Increased By ▲ 0.56 (6.81%)
TREET 24.65 Increased By ▲ 0.12 (0.49%)
TRG 71.50 Increased By ▲ 1.79 (2.57%)
WAVES 10.01 Increased By ▲ 0.07 (0.7%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
Topic

BioNTech vaccines

Foxconn founder says hopes to import BioNTech COVID shots for Taiwan

Foxconn founder says hopes to import BioNTech COVID shots for Taiwan

Published 29 May, 2021 06:21pm
  • In a statement, Gou said that his Yonglin Foundation plans to apply for 5 million BioNTech doses made and packaged in Germany to be imported into Taiwan.
  • The shots would be airlifted from Germany to Taiwan without going via any middleman, he added.
Early backers of vaccine maker BioNTech in $719 million payday

Early backers of vaccine maker BioNTech in $719 million payday

Published 04 Feb, 2021 08:42pm
  • MIG said on Thursday that investors in its funds would now receive 340 million euros from the sale of an unspecified stake in BioNTech, following a payout of 260 million euros last year.
  • BioNTech now has a market capitalisation of around $28.4 billion, more than eight times its valuation of $3.4 billion.
Pfizer sees about $15bn in 2021 sales from COVID-19 vaccine

Pfizer sees about $15bn in 2021 sales from COVID-19 vaccine

Updated 02 Feb, 2021 08:12pm
  • The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.
  • The vaccine was among the first to be authorized for emergency use in the United States and several other countries, and analysts have forecast billions in sales.
Ukraine will receive 117,000 doses of Pfizer vaccine in February

Ukraine will receive 117,000 doses of Pfizer vaccine in February

Published 30 Jan, 2021 06:52pm
  • Manufactured in the United States, the Pfizer-BioNTech vaccine will be immediately distributed to vaccinate employees of hospitals that provide care to patients with COVID.
  • In parallel, during the first half of the year, starting from February, we will be able to receive between 2.2 and 3.7 million doses of AstraZeneca / Oxford vaccine for the next phases of the campaign.
Germany secured 50mn vaccine doses from CureVac, BioNTech on top of EU supplies

Germany secured 50mn vaccine doses from CureVac, BioNTech on top of EU supplies

Published 08 Jan, 2021 08:17pm
  • The ministry official, speaking on condition of anonymity, said Germany signed a memorandum of understanding with CureVac on Aug. 31 for the supply of 20 million doses of its vaccine under development.
  • The internal health ministry document dated Jan. 7 and seen by Reuters had the same figures.
Germany says does not intend to delay second COVID-19 vaccine shot

Germany says does not intend to delay second COVID-19 vaccine shot

Published 06 Jan, 2021 06:49pm
  • Germany has asked an independent expert panel for advice on whether to allow a delay in administering the second dose to make scarce supplies go further.
  • My impression is that it makes a lot of sense, especially with these sensitive issues, where trust and reliability are important.
BioNTech founders warn of vaccine supply gaps: Spiegel

BioNTech founders warn of vaccine supply gaps: Spiegel

Published 01 Jan, 2021 05:51pm
  • CEO Sahin says can't fully cover lack of other vaccines.
  • Says testing BioNTech/Pfizer vaccine on UK COVID variant.
  • Says could tweak vaccine for strong mutations in 6 weeks.
  • BioNTech may have more easily storable vaccine by summer.
Loading...